[1]Hamers-Casterman C , Atarhouch T , Muyldermans S , et al. Naturally occurring antibodies devoid of light chains[J]. Nature, 1993, 363(6428):446-448. [2] Harmsen M M , Haard H J D . Properties, production, and applications of camelid single-domain antibody fragments [J]. Applied Microbiology and Biotechnology, 2007, 77(1):13-22. [3]Beno t Stijlemans, Katja Conrath, Virna Cortez-Retamozo, Serge Muyldermans, and Stefan Magez. Efficient Targeting of Conserved Cryptic Epitopes of Infect Agents by Single Domain Antibodies. [J]. Journal of Biological Chemistry, 279(2):1256-1261. [4]Lauwereys M , Ghahroudi M A , Desmyter A , et al. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies[J]. Embo Journal, 1998, 17(13):3512-3520. [5]Genst E D , Silence K , Decanniere K , et al. Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies[C]. Proceedings of the National Academy of Sciences of the United States of America , 2006, 103(12):4586-4591. [6]Serge Muyldermans. Nanobodies: Natural Single-Domain Antibodies [J]. Annual Review of Biochemistry, 2013, 82(1):775-97. [7]Jiang-Wei Li, Lijie Xia, Youhong Su, Hongchun Liu, Xueqing Xia, Qinxia Lu, Chunjin Yang and Kalbinur Reheman. Molecular imprint of the enzyme active site by camel nanobodies: rapid and efficient approach to produce abzymes with alliinase activity [J]. Journal of Biological Chemistry, 2012, 287(17):13713-13721. [8]QIU L, FENG Y, MA X, LI J. A camel anti-lysozyme CDR3 only domain antibody selected from phage display VHH library acts as potent lysozyme inhibitor [J]. Acta Biochim Biophys Sin. 2017,49(6):513-519. [9]Nguyen V , Su C , Muyldermans S , et al. Heavy-chain antibodies inCamelidae; a case of evolutionary innovation[J]. Immunogenetics, 2002, 54(1):39-47. [10]Vermeer A W P , Norde W . The Thermal Stability of Immunoglobulin: Unfolding and Aggregation of a Multi-Domain Protein [J]. Biophysical Journal, 2000, 78(1):394-404. [11]Akazawa-Ogawa Y, Nagai H, Hagihara Y. Heat denaturation of the antibody, a multi-domain protein [J]. Biophysical Reviews, 2018;10(2):255-258. [12]Neergaard MS, Nielsen AD, Parshad H, Van De Weert M. Stability of monoclonal antibodies at high-concentration: head-to-head comparison of the IgG1 and IgG4 subclass. J Pharm Sci. 2014;103(1):115-127. [13]van der Linden, R. H., Frenken, L. G., de Geus, B., Harmsen, M. M., Ruuls, R. C., Stok, W.,de Ron, L., Wilson, S., Davis, P., and Verrips, C. T. Comparison of physical chemicalproperties of llama VHH antibody fragments and mouse monoclonal antibodies. Biochim Biophys Acta, 1999, 1431: 37-46. [14] Akazawa-Ogawa Y, Uegaki K, Hagihara Y. The role of intra-domain disulfide bonds in heat-induced irreversible denaturation of camelid single domain VHH antibodies[J]. Journal of Biochemistry, 2015, 159(1):111-121. [15]Kunz P, Zinner K, Norbert Mücke, et al. The structural basis of nanobody unfolding reversibility and thermoresistance [J]. Scientific Reports, 2018, 8(1):7934-7945. [16]Kunz P, Flock T, Soler N, et al. Exploiting sequence and stability information for directing nanobody stability engineering[J]. Biochimica et Biophysica Acta (BBA) - General Subjects, 2017, 1861(9):2196-2205. [17]Dan Z, Anderson G P, Nikhil B, et al. Contributions of the Complementarity Determining Regions to the Thermal Stability of a Single-Domain Antibody[J]. PLoS ONE, 2013, 8(10):e77678-. ons to the thermal stability of a single-domain antibody. PLoS One. 2013, 8(10):e77678. [18]Govaert J, Pellis M, Deschacht N, Vincke C, Conrath K, Muyldermans S, Saerens D. Dual beneficial effect of interloop disulfide bond for single domain antibody fragments. J Biol Chem. 2012,287(3):1970-1979. [19]Perez, J. M., Renisio, J. G., Prompers, J. J., van Platerink, C. J., Cambillau, C., Darbon, H.,and Frenken, L. G. Thermal unfolding of a llama antibody fragment: a two-state reversible process. Biochemistry .2001,40:74-83. [20]Dumoulin M , Conrath K, Meirhaeghe A V, et al. Single-domain antibody fragments with high conformational stability[J]. Protein Science, 2002, 11(3):500-515. [21]Ladenson, R. C., Crimmins, D. L., Landt, Y., and Ladenson, J. H. Isolation andcharacterization of a thermally stable recombinant anti-caffeine heavy-chain antibodyfragment. Anal Chem .2006,78:4501-4508. [22]Ewert S, Cambillau C, Conrath K, et al. Biophysical Properties of Camelid V_HH Domains Compared to Those of Human V_H3 Domains[J]. Biochemistry, 2002, 41(11):3628-3636. [23]Ingram J R, Schmidt F I, Ploegh H L. Exploiting Nanobodies\" Singular Traits[J]. Annual Review of Immunology, 2018, 36(1): 695-715. |